Fiorentino F, Canali B, Morelli P, Demma F. Brentuximab vedotin in combination with doxorubicin, vinblastine and dacarbazine for first-line treatment of stage IV HL: cost impact on subsequent lines in Italy. AboutOpen [Internet]. 2023 Jan. 16 [cited 2024 Nov. 23];10(1):6-12. Available from: https://journals.aboutscience.eu/index.php/aboutopen/article/view/2486